Different Transcutaneous Electrical Nerve Stimulation Modes in Pudendal Neuralgia Post-prostatectomy (NCT07348952) | Clinical Trial Compass
CompletedNot Applicable
Different Transcutaneous Electrical Nerve Stimulation Modes in Pudendal Neuralgia Post-prostatectomy
Egypt60 participantsStarted 2023-09-01
Plain-language summary
The purpose of this study was to evaluate the therapeutic efficacy of two different Transcutaneous Electrical Nerve Stimulation modes in improving the pudendal neuralgia and its intractable perineal pain.
Who can participate
Age range50 Years – 60 Years
SexMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Patients will be chosen after a routine medical examination.
* All patients will be approximately the same age (from 50-60 years old).
* All patients have chronic pudendal neuralgia post-prostatectomy surgery.
* They have not take another physical therapy electro- modality except the traditional physical therapy in the form of pelvic floor exercises.
* All of them will be non smokers and will be under own prescribed medications described by their physicians.
* The pain is located in the pudendal nerve distribution area.
* Pain intensity increased in the sitting position.
* There were no symptoms of nocturnal pain.
* Pain with no objective sensory impairment.
* Pain was relieved by diagnostic pudendal nerve block.
* Another clinical standard provides extra support to the diagnosis of pudendal neuralgia.
* Pain symptoms may be associated with sexual dysfunction.
Exclusion Criteria:
* Patients have simple tailbone, gluteus muscle or lower abdominal pain, or only paroxysmal pain, or only pruritic symptoms, and/or having imaging anomalies that may explain the symptoms.
* Patients who take anticoagulant drugs or have any coagulation disorder.
* Patients who will be unable to complete the study.
* Patients with pain, which is caused by malignant or autoimmune diseases.
* Patients with life threatening disorders as renal failure, myocardial infarction or others will be excluded from the study.
* Patients who suffering from skin diseases, diabetes, varicose ve…